Genetic Susceptibility to Human Norovirus Infection: An Update
- PMID: 30845670
- PMCID: PMC6466115
- DOI: 10.3390/v11030226
Genetic Susceptibility to Human Norovirus Infection: An Update
Abstract
Noroviruses are the most common etiological agent of acute gastroenteritis worldwide. Despite their high infectivity, a subpopulation of individuals is resistant to infection and disease. This susceptibility is norovirus genotype-dependent and is largely mediated by the presence or absence of human histo-blood group antigens (HBGAs) on gut epithelial surfaces. The synthesis of these HBGAs is mediated by fucosyl- and glycosyltransferases under the genetic control of the FUT2 (secretor), FUT3 (Lewis) and ABO(H) genes. The so-called non-secretors, having an inactivated FUT2 enzyme, do not express blood group antigens and are resistant to several norovirus genotypes, including the predominant GII.4. Significant genotypic and phenotypic diversity of HBGA expression exists between different human populations. Here, we review previous in vivo studies on genetic susceptibility to norovirus infection. These are discussed in relation to population susceptibility, vaccines, norovirus epidemiology and the impact on public health.
Keywords: histo-blood group antigens; norovirus; secretor status; susceptibility.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
FUT2, Secretor Status and FUT3 Polymorphisms of Children with Acute Diarrhea Infected with Rotavirus and Norovirus in Brazil.Viruses. 2020 Sep 25;12(10):1084. doi: 10.3390/v12101084. Viruses. 2020. PMID: 32992989 Free PMC article.
-
Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection.mBio. 2020 Mar 17;11(2):e00251-20. doi: 10.1128/mBio.00251-20. mBio. 2020. PMID: 32184242 Free PMC article.
-
Innate Susceptibility to Norovirus Infections Influenced by FUT2 Genotype in a United States Pediatric Population.Clin Infect Dis. 2015 Jun 1;60(11):1631-8. doi: 10.1093/cid/civ165. Epub 2015 Mar 5. Clin Infect Dis. 2015. PMID: 25744498 Free PMC article.
-
[Genetic susceptibility to norovirus infection].Pathol Biol (Paris). 2013 Jan;61(1):28-35. doi: 10.1016/j.patbio.2013.01.002. Epub 2013 Feb 8. Pathol Biol (Paris). 2013. PMID: 23399413 Review. French.
-
Mendelian resistance to human norovirus infections.Semin Immunol. 2006 Dec;18(6):375-86. doi: 10.1016/j.smim.2006.07.009. Epub 2006 Sep 14. Semin Immunol. 2006. PMID: 16973373 Free PMC article. Review.
Cited by
-
Culture of Human Rotaviruses in Relevant Models Shows Differences in Culture-Adapted and Nonculture-Adapted Strains.Int J Mol Sci. 2023 Dec 11;24(24):17362. doi: 10.3390/ijms242417362. Int J Mol Sci. 2023. PMID: 38139191 Free PMC article.
-
Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity.Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0063623. doi: 10.1128/aac.00636-23. Epub 2023 Oct 3. Antimicrob Agents Chemother. 2023. PMID: 37787556 Free PMC article.
-
Unraveling the interplay between norovirus infection, gut microbiota, and novel antiviral approaches: a comprehensive review.Front Microbiol. 2023 Jul 6;14:1212582. doi: 10.3389/fmicb.2023.1212582. eCollection 2023. Front Microbiol. 2023. PMID: 37485533 Free PMC article. Review.
-
Immunogenicity and Blocking Efficacy of Norovirus GII.4 Recombinant P Protein Vaccine.Vaccines (Basel). 2023 Jun 1;11(6):1053. doi: 10.3390/vaccines11061053. Vaccines (Basel). 2023. PMID: 37376442 Free PMC article.
-
A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide.bioRxiv [Preprint]. 2023 May 23:2023.05.23.542011. doi: 10.1101/2023.05.23.542011. bioRxiv. 2023. PMID: 37293103 Free PMC article. Updated. Preprint.
References
-
- Becker-Dreps S., Bucardo F., Vilchez S., Zambrana L.E., Liu L., Weber D.J., Pena R., Barclay L., Vinje J., Hudgens M.G., et al. Etiology of childhood diarrhea after rotavirus vaccine introduction: A prospective, population-based study in Nicaragua. Pediatr. Infect. Dis. J. 2014;33:1156–1163. doi: 10.1097/INF.0000000000000427. - DOI - PMC - PubMed
-
- Hemming M., Rasanen S., Huhti L., Paloniemi M., Salminen M., Vesikari T. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Eur. J. Pediatr. 2013;172:739–746. doi: 10.1007/s00431-013-1945-3. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
